- Home
- PLAY vs EYPT Comparison
PLAY vs EYPT Comparison
Compare PLAY & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLAY
- EYPT
- Stock Information
- Founded
- PLAY 1982
- EYPT 1987
- Country
- PLAY United States
- EYPT United States
- Employees
- PLAY N/A
- EYPT N/A
- Industry
- PLAY Restaurants
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- PLAY Consumer Discretionary
- EYPT Industrials
- Exchange
- PLAY Nasdaq
- EYPT Nasdaq
- Market Cap
- PLAY 678.9M
- EYPT 579.4M
- IPO Year
- PLAY 1995
- EYPT 2005
- Fundamental
- Price
- PLAY $31.48
- EYPT $9.48
- Analyst Decision
- PLAY Hold
- EYPT Strong Buy
- Analyst Count
- PLAY 8
- EYPT 8
- Target Price
- PLAY $31.83
- EYPT $24.75
- AVG Volume (30 Days)
- PLAY 1.6M
- EYPT 821.1K
- Earning Date
- PLAY 06-10-2025
- EYPT 08-06-2025
- Dividend Yield
- PLAY N/A
- EYPT N/A
- EPS Growth
- PLAY N/A
- EYPT N/A
- EPS
- PLAY 1.02
- EYPT N/A
- Revenue
- PLAY $2,112,300,000.00
- EYPT $56,042,000.00
- Revenue This Year
- PLAY $3.62
- EYPT N/A
- Revenue Next Year
- PLAY $6.33
- EYPT N/A
- P/E Ratio
- PLAY $29.59
- EYPT N/A
- Revenue Growth
- PLAY N/A
- EYPT 12.04
- 52 Week Low
- PLAY $15.08
- EYPT $3.91
- 52 Week High
- PLAY $43.73
- EYPT $13.99
- Technical
- Relative Strength Index (RSI)
- PLAY 63.74
- EYPT 72.76
- Support Level
- PLAY $30.90
- EYPT $7.94
- Resistance Level
- PLAY $32.58
- EYPT $10.77
- Average True Range (ATR)
- PLAY 1.59
- EYPT 0.74
- MACD
- PLAY -0.11
- EYPT 0.10
- Stochastic Oscillator
- PLAY 70.91
- EYPT 85.87
About PLAY Dave & Buster's Entertainment Inc.
Dave & Buster's Entertainment Inc owns and operates nearly a hundred entertainment and dining establishments in the United States where customers can eat, drink, play games, and watch televised sports. Each store offers a full menu of entries and appetizers, a complete selection of alcoholic and non-alcoholic beverages, and an extensive assortment of entertainment attractions centered around playing games and watching live sports and other televised events. It derives maximum revenue from Entertainment.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.